Specialization
bladder cancer
-
Phase 1 Study of Chemoradiotherapy Combined with Nivolumab ± Ipilimumab for the Curative Treatment of Muscle-invasive Bladder Cancer
de Ruiter, B. M., van Hattum, J. W., Lipman, D., de Reijke, T. M., van Moorselaar, R. J. A., van Gennep, E. J., Maartje Piet, A. H., Donker, M., van der Hulle, T., Voortman, J., Oddens, J. R., Hulshof, M. C. C. M. & Bins, A. D., Nov 2022, In: European Urology. 82, 5, p. 518-526 9 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Bladder-sparing chemoradiotherapy combined with immune checkpoint inhibition for locally advanced urothelial bladder cancer—a review
van Hattum, J. W., de Ruiter, B-M., Oddens, J. R., Hulshof, M. C. C. M., de Reijke, T. M. & Bins, A. D., 1 Jan 2022, In: Cancers. 14, 1, 38.Research output: Contribution to journal › Review article › Academic › peer-review
-
The Effect of Metformin on Bladder Cancer Incidence and Outcomes: A Systematic Review and Meta-Analysis
van Hattum, J. W., de Ruiter, B. M., Oddens, J. R., de Reijke, T. M., Wilmink, J. W. & Molenaar, R. J., 2022, In: Bladder Cancer. 8, 2, p. 211-228 18 p.Research output: Contribution to journal › Review article › Academic › peer-review
- All publications